Primary Record
Talmapimod
- In stock
- 3,110 g
- Purity
- 98.5 %
- CAS
- 309913-83-5
Compound Identifiers & Properties
- CAS
- 309913-83-5
- PubChem CID
- 9871074
- SMILES
- C[C@@H]1CN([C@H](CN1C(=O)C2=C(C=C3C(=C2)C(=CN3C)C(=O)C(=O)N(C)C)Cl)C)CC4=CC=C(C=C4)F
- Canonical SMILES
- C[C@@H]1CN(Cc2ccc(F)cc2)[C@@H](C)CN1C(=O)c1cc2c(C(=O)C(=O)N(C)C)cn(C)c2cc1Cl
Names & Synonyms
- Talmapimod
- SCIO-469
- talmapimodum
- Scios 469
- rac-Talmapimod
- 309913-83-5
- SCIO 469
- Talmapimod [USAN]
- SCIO 469 hydrochloride
- Talmapimod [USAN:INN]
- B1E00KQ6NT
- Talmapimod hydrochloride
- UNII-B1E00KQ6NT
- TALMAPIMOD [INN]
- RefChem:890880
- Talmapimod (USAN/INN)
- D04HWF
- CHEMBL514201
- TALMAPIMOD [WHO-DD]
- C27H30ClFN4O3
- SCIO469
- CHEBI:90683
- MLS006010308
- GTPL7817
- orb1309113
- SCHEMBL4779242
- SCHEMBL29394770
- SCHEMBL29437775
- 309913-83-5 (free base)
- DTXSID10953119
- GLXC-27441
- AMX10193
- BDBM50266947
- EX-A11087
- NSC777446
- NSC800941
- ZINC34001955
- AKOS030526777
- CID9871074
- CS-5645
- DB05412
- NSC-777446
- NSC-800941
- CID 9871074
- CID:9871074
- NCGC00263140-01
- NCGC00263140-03
- AN-28986
- FT103944
- HY-10406
- MS-29524
- SID:53789617
- SMR004701374
- NS00072037
- A12770
- D09386
- E98853
- Q-9272
- 913T835
- A919558
- C499748
- BRD-K17555800-001-01-9
- BRD-K17555800-003-01-5
- Q27088933
- 1H-Indole-3-acetamide, 6-chloro-5-[[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-N,N,1-trimethyl-alpha-oxo-
- 2-(6-chloro-5-((2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazine-1-carbonyl)-1-methyl-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide
- 309915-13-7
- 2-(6-Chloro-5-{[(2r,5s)-4-(4-Fluorobenzyl)-2,5-Dimethylpiperazin-1-Yl]carbonyl}-1-Methyl-1h-Indol-3-Yl)-N,N-Dimethyl-2-Oxoacetamide
- 2-[6-chloro-5-[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethylpiperazine-1-carbonyl]-1-methylindol-3-yl]-N,N-dimethyl-2-oxoacetamide
- 1H-Indole-3-acetamide, 6-chloro-5-(((2R,5S)-4-((4-fluorophenyl)methyl)-2,5-dimethyl-1-piperazinyl)carbonyl)-N,N,1-trimethyl-alpha-oxo-
- 2-(6-chloro-5-(((2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazin-1-yl)carbonyl)-1-methyl-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide
- 2-(6-chloro-5-{(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethylpiperazine-1-carbonyl}-1-methyl-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide
- 2-[6-chloro-5-[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethyl-piperazine-1-carbonyl]-1-methyl-indol-3-yl]-N,N-dimethyl-2-oxo-acetamide
- 1H-INDOLE-3-ACETAMIDE, 6-CHLORO-5-(((2R,5S)-4-((4-FLUOROPHENYL)METHYL)-2,5-DIMETHYL-1-PIPERAZINYL)CARBONYL)-N,N,1-TRIMETHYL-.ALPHA.-OXO-
- 1H-Indole-3-acetamide, 6-chloro-5-[[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-N,N,1-trimethyl-a-oxo-
- 2-(6-chloro-5-((2R,5S)-4-((4-fluorophenyl)methyl)-2,5-dimethylpiperazine-1-carbonyl)-1-methyl-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide
- 2-(6-chloro-5-((2R,5S)-4-((4-fluorophenyl)methyl)-2,5-dimethylpiperazine-1-carbonyl)-1-methylindol-3-yl)-N,N-dimethyl-2-oxoacetamide
- 2-(6-Chloro-5-{4-[(4-fluorophenyl)methyl]-2,5-dimethylpiperazine-1-carbonyl}-1-methyl-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide
- 2-[6-Chloro-5-[[(2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazin-1-yl]carbonyl]-1-methyl-1H-indol-3-yl]-N,N-dimethyl-2-oxoacetamide
- 6-Chloro-5-[[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-N,N,1-trimethyl-|A-oxo-1H-indole-3-acetamide
- 6-Chloro-5-[[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-N,N,1-trimethyl-alpha-oxo-1H-indole-3-acetamide
- 750646-72-1
- rel-6-Chloro-5-[[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-N,N,1-trimethyl-a-oxo-1H-indole-3-acetamide; SCIO 282; SD 282